ppanPersonalized Psychiatry and NeurologyPersonalized Psychiatry and Neurology2712-9179V. M. Bekhterev National Medical Research Centre for Psychiatry and Neurology of the Ministry of Health of the Russian Federation (Bekhterev NMRC PN)10.52667/10.52667/2712-9179-2024-4-1-18-25ppan-93Research ArticleARTICLEThe Frequency and Structure of Adverse Drug Reactions in the Pharmacotherapy of EpilepsyBochanovaE. A.

Elena A. Bochanova

Krasnoyarsk 660022

bochanova@list.ruGusevS. D.

Sergey D. Gusev

Krasnoyarsk 660022

V.F. Voino-Yasenetsky Krasnoyarsk State Medical UniversityRussian Federation202425032024411825Copyright © Bochanova E.A., Gusev S.D., 20242024Bochanova E.A., Gusev S.D.Bochanova E.A., Gusev S.D.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.jppn.ru/jour/article/view/93

The problem of the safety of antiepileptic therapy due to the duration of treatment and the need for regular intake of antiepileptic drugs (AEDs) is extremely significant. Adverse reactions (ADRs) may outweigh any positive effect of therapy associated with seizure reduction. The purpose of the study: to analyze the frequency and structure of ADRs of AEDs. Materials and Methods: The work was carried out within the framework of comprehensive research on the topic No. 210-16 "Epidemiological, genetic and neurophysiological aspects of diseases of the nervous system (central, peripheral and vegetative) and preventive medicine" (registration number 0120.0807480). Results: The frequency of ADRs against the background of third-generation AEDs was not inferior to that against the background of receiving second-generation AEDs, while the structure of ADRs was different: third-generation AEDs had a higher incidence of ADRs from the central nervous system, including a worsening of the course of epilepsy. The ratio of the chances of valproic acid accumulation with the achievement of toxic concentration in the blood and the development of un-desirable side effects in poor metabolizers (carriers of the polymorphism of CYP2C9*2 or CYP2C9*3) the gene encoding the cytochrome P450 isoenzyme 2C9 of the liver is 5.94 and 4.27, respectively. Conclusion: A personalized approach to ensuring the safety of valproic acid preparations based on taking into account the carriage of polymorphisms of the CYP2C9 gene allows to reduce the incidence of ADRs in patients receiving valproic acid preparations from 59.28% to 10.78%. The introduction of a personalized approach to the administration of valproates to patients suffering from epilepsy in the Krasnoyarsk Territory did not lead to an increase in direct costs.

bipolar affective disorderpharmacogenetic testingtreatmentsafetyReferencesShnayder, N.A.; Pilyugina, M.S.; Dmitrenko, D.V.; Bochanova, E.N.; Shapovalova, E.A.; Erikalova, S.A.; Shmatova, E.N.; Khamraeva, E.H. Pharmacogenetics of valproic acid as unmodified risk factor of adverse drug reactions. Medical and Health Science Journal. 2011;7:20-28.Shnayder, N.A.; Pilyugina, M.S.; Dmitrenko, D.V.; Bochanova, E.N.; Shapovalova, E.A.; Erikalova, S.A.; Shmatova, E.N.; Khamraeva, E.H. Pharmacogenetics of valproic acid as unmodified risk factor of adverse drug reactions. Medical and Health Science Journal. 2011;7:20-28.Shnayder, N.A.; Sychev, D.A.; Pilyugina, M.S.; Dmitrenko, D.V.; Bochanova, E.N.; Shapovalova, E.A. The importance of valproic acid pharmacogenetics in an individual approach to the treatment of women of fertile age suffering from epilepsy. S.S. Korsakov Journal of Neurology and Psychiatry. Issue 2 Epilepsy. 2011;111(5):31-37. (in Russ.)Shnayder, N.A.; Sychev, D.A.; Pilyugina, M.S.; Dmitrenko, D.V.; Bochanova, E.N.; Shapovalova, E.A. The importance of valproic acid pharmacogenetics in an individual approach to the treatment of women of fertile age suffering from epilepsy. S.S. Korsakov Journal of Neurology and Psychiatry. Issue 2 Epilepsy. 2011;111(5):31-37. (in Russ.)Shnayder, N.A.; Pilyugina, M.S.; Dmitrenko, D.V.; Shapovalova, E.A.; Bochanova, E.N. Toxicity of valproic acid preparations. Clinical Pharmacology and Pharmacoeconomics. 2011;4(3):15-27. (in Russ.)Shnayder, N.A.; Pilyugina, M.S.; Dmitrenko, D.V.; Shapovalova, E.A.; Bochanova, E.N. Toxicity of valproic acid preparations. Clinical Pharmacology and Pharmacoeconomics. 2011;4(3):15-27. (in Russ.)Shnaider, N.A.; Sychev, D.A.; Pilyugina, M.S.; Dmitrenko, D.V.; Bochanova, E.N.; Shapovalova, E.A. Importance of the pharmacokinetics of valproic acid in an individualized approach to the treatment of epileptic women of fertile age. Neuroscience and Behavioral Physiology. 2012;42(9):963-968.Shnaider, N.A.; Sychev, D.A.; Pilyugina, M.S.; Dmitrenko, D.V.; Bochanova, E.N.; Shapovalova, E.A. Importance of the pharmacokinetics of valproic acid in an individualized approach to the treatment of epileptic women of fertile age. Neuroscience and Behavioral Physiology. 2012;42(9):963-968.Dmitrenko, D.V.; Shnayder, N.A.; Egorova, A.T.; Bochanova, E.N.; Veselova, O.F.; Kantimirova, E.A.; Sadykova, A.V.; Shapovalova, E.A. Epilepsy and pregnancy: a monograph. Moscow, Medica Publishing House 2014:142.Dmitrenko, D.V.; Shnayder, N.A.; Egorova, A.T.; Bochanova, E.N.; Veselova, O.F.; Kantimirova, E.A.; Sadykova, A.V.; Shapovalova, E.A. Epilepsy and pregnancy: a monograph. Moscow, Medica Publishing House 2014:142.Shnayder, N.A.; Dmitrenko, D.V.; Veselova, O.F.; Bochanova, E.N. Role of pharmacogenetics in prevention of valproate-induced adverse drug reactions from central neurous system. Abstract Book International Congress on Neuroscince / Edited by A.B. Salmina, M.M. Petrova, E.A. Pozhilenkova. Krasnoyarsk, KrasGMU 2014: 91. (in Russ.)Shnayder, N.A.; Dmitrenko, D.V.; Veselova, O.F.; Bochanova, E.N. Role of pharmacogenetics in prevention of valproate-induced adverse drug reactions from central neurous system. Abstract Book International Congress on Neuroscince / Edited by A.B. Salmina, M.M. Petrova, E.A. Pozhilenkova. Krasnoyarsk, KrasGMU 2014: 91. (in Russ.)Dmitrenko, D.V.; Shnayder, N.A.; Kiselev, I.A.; Shulmin, A.V.; Zhirova, N.V.; Shapovalova, E.A.; Kantimirova, E.A.; Bochanova, E.N.; Veselova, O.F.; Panina, Yu.S.; Muravieva, A.V. Problems of rational therapy for epilepsy during pregnancy. Open Journal of Obstetrics and Gynecology 2014;4(9):506-515.Dmitrenko, D.V.; Shnayder, N.A.; Kiselev, I.A.; Shulmin, A.V.; Zhirova, N.V.; Shapovalova, E.A.; Kantimirova, E.A.; Bochanova, E.N.; Veselova, O.F.; Panina, Yu.S.; Muravieva, A.V. Problems of rational therapy for epilepsy during pregnancy. Open Journal of Obstetrics and Gynecology 2014;4(9):506-515.Bochanova, E.N.; Veselova, O.F..; Shnayder, N.A.; Dmitrenko, D.V.; Zhuravlev, D.V. Assessment of the frequency of off-label prescribing of drugs for children with epilepsy. In: Abstract Book of the V Anniversary Baltic Congress on Pediatric Neurology. Man and His Health. St. Petersburg, 2015:68. (in Russ.)Bochanova, E.N.; Veselova, O.F..; Shnayder, N.A.; Dmitrenko, D.V.; Zhuravlev, D.V. Assessment of the frequency of off-label prescribing of drugs for children with epilepsy. In: Abstract Book of the V Anniversary Baltic Congress on Pediatric Neurology. Man and His Health. St. Petersburg, 2015:68. (in Russ.)Dmitrenko, D.V.; Shnayder, N.A.; Govorina, Yu.B.; Bochanova, E.N.; Fateeva, E.A.; Dedyuk, N.A.; Mustafaeva, A.V. Genetic features of valproate metabolism as a risk factor for the development of undesirable drug phenomena. Modern Problems of Science and Education. 2015;5. URL: http://www.science-education.ru/128-22340 (in Russ.)Dmitrenko, D.V.; Shnayder, N.A.; Govorina, Yu.B.; Bochanova, E.N.; Fateeva, E.A.; Dedyuk, N.A.; Mustafaeva, A.V. Genetic features of valproate metabolism as a risk factor for the development of undesirable drug phenomena. Modern Problems of Science and Education. 2015;5. URL: http://www.science-education.ru/128-22340 (in Russ.)Dmitrenko, D.V.; Shnayder, N.A.; Govorina, Yu.B.; Nikolaeva, T.Ya.; Popova, T.E.; Sharavii, L.K.; Muravieva, A.V.; Bochanova, E.N.; Fateeva, E.A.; Dedyuk, N.A.; Mustafaeva, A.V.; Dyuzhakova, A.V.; Andreev, M.E.; Ozhegov, P.S.; Sofronova, G.I.; Prokopieva, A.G.; Androsova, Z.P.; Fedorova, V.V.; Basova, E.V.; Stroganova, M.A. Ethnic aspects of the carriage of polymorphisms of the CYP2C9 gene in children and adolescents with epilepsy in Eastern and Northeastern Siberia. Modern Problems of Science and Education 2015;6; URL: http://www.science-education.ru/130-23133 (in Russ.)Dmitrenko, D.V.; Shnayder, N.A.; Govorina, Yu.B.; Nikolaeva, T.Ya.; Popova, T.E.; Sharavii, L.K.; Muravieva, A.V.; Bochanova, E.N.; Fateeva, E.A.; Dedyuk, N.A.; Mustafaeva, A.V.; Dyuzhakova, A.V.; Andreev, M.E.; Ozhegov, P.S.; Sofronova, G.I.; Prokopieva, A.G.; Androsova, Z.P.; Fedorova, V.V.; Basova, E.V.; Stroganova, M.A. Ethnic aspects of the carriage of polymorphisms of the CYP2C9 gene in children and adolescents with epilepsy in Eastern and Northeastern Siberia. Modern Problems of Science and Education 2015;6; URL: http://www.science-education.ru/130-23133 (in Russ.)Shnayder, N.A.; Dmitrenko, D.V.; Govorina, Yu.B.; Muravieva, A.V.; Kotlovsky, Yu.V.; Bochanova, E.N.; Fateeva, E.A.; Dedyuk, N.A.; Mustafaeva, A.V. The effect of CYP2C9 gene polymorphism on valproic acid levels in women of reproductive age with epilepsy. Pharmacogenetics and Pharmacogenomics 2015;2:19-23. (in Russ.)Shnayder, N.A.; Dmitrenko, D.V.; Govorina, Yu.B.; Muravieva, A.V.; Kotlovsky, Yu.V.; Bochanova, E.N.; Fateeva, E.A.; Dedyuk, N.A.; Mustafaeva, A.V. The effect of CYP2C9 gene polymorphism on valproic acid levels in women of reproductive age with epilepsy. Pharmacogenetics and Pharmacogenomics 2015;2:19-23. (in Russ.)Bochanova, E.N.; Zhuravlev, D.A.; Veselova, O.F.; Shnayder, N.A.; Dmitrenko, V.V. Using the ATC methodology/To assess the consumption of antiepileptic drugs in the Krasnoyarsk Territory. In: The Book of abstracts of the Congress "Epileptology in the System of Neuroscience". St. Petersburg, 2015:52-53. (in Russ.)Bochanova, E.N.; Zhuravlev, D.A.; Veselova, O.F.; Shnayder, N.A.; Dmitrenko, V.V. Using the ATC methodology/To assess the consumption of antiepileptic drugs in the Krasnoyarsk Territory. In: The Book of abstracts of the Congress "Epileptology in the System of Neuroscience". St. Petersburg, 2015:52-53. (in Russ.)Bochanova, E.N.; Zhuravlev, D.A.; Nozdrachev, K.G.; Bogdanov, V.V.; Shnayder, N.A.; Dmitrenko, D.V.; Kozhukhova, E.I.; Bikulova, T.V. Organization of preferential drug provision for patients with epilepsy in the Krasnoyarsk Territory. Epilepsy and Paroxysmal Disorders 2015;3:24-31 (in Russ.)Bochanova, E.N.; Zhuravlev, D.A.; Nozdrachev, K.G.; Bogdanov, V.V.; Shnayder, N.A.; Dmitrenko, D.V.; Kozhukhova, E.I.; Bikulova, T.V. Organization of preferential drug provision for patients with epilepsy in the Krasnoyarsk Territory. Epilepsy and Paroxysmal Disorders 2015;3:24-31 (in Russ.)

The authors declare that there are no conflicts of interest present.